Myopia's Market Assessment & Forecast

Objective

DelveInsight’s comprehensive myopia market assessment and forecast analysis equipped the client with data-driven insights on pediatric myopia epidemiology, enabling them to design targeted strategies aligned with age-specific and severity-specific patient segments. Leveraging accurate intelligence on myopia prevalence, disease burden, and treatment adoption trends, the client was able to refine strategic planning, optimize resource allocation, and evaluate potential growth opportunities across key APAC markets.

Additionally, an in-depth understanding of the competitive landscape, evolving treatment paradigms, and market drivers empowered the client to make informed decisions related to market entry, product differentiation, pricing strategy, and long-term positioning, ultimately supporting enhanced market share and revenue forecasting.

Problem Statement

The client engaged DelveInsight to conduct a detailed epidemiological and market study of pediatric myopia, with a focus on APAC countries where myopia prevalence is escalating rapidly. The key objectives included:

• Analyzing the current and emerging treatment approaches for myopia in children
• Estimating the myopia market size and understanding country-level market dynamics
• Assessing the shifts in the treatment paradigm, from symptomatic management to therapeutic interventions
• Forecasting treatment uptake and therapy-wise market share up to 2032
• Profiling age-based and severity-specific patient pools, including the burden of moderate-to-severe myopia
• Benchmarking treatment vs. symptomatic management trends across individual APAC markets
  
  

This analysis was aimed at enabling precise targeting of high-opportunity patient groups and understanding competitive positioning in rapidly growing myopia markets.

Our Methodology

Our evaluation followed a structured, multi-layered research model aligned with DelveInsight’s proven market intelligence framework:

1. Epidemiology Analysis & Patient Segmentation

We initiated an exhaustive epidemiological study to identify myopia prevalence, incidence, and progression trends across major APAC regions. This included:

• Age-stratified epidemiology for children aged 3–17
• Severity-based segmentation (mild, moderate, severe myopia)
• Assessment of high-risk demographic clusters in China, Japan, South Korea, and Southeast Asia
  
  

This allowed us to accurately size the target patient pool, with emphasis on moderate-to-severe pediatric myopia, which represented the core focus for the client.

2. APAC Market Assessment & Competitive Landscape Mapping

DelveInsight conducted robust market evaluations across prominent markets such as China, South Korea, Japan, Singapore, and other APAC regions, analyzing:

• Current standard of care
• Uptake of emerging therapies
• Penetration of orthokeratology (Ortho-K), atropine therapy, spectacles, and combination management techniques
• Dominance of symptomatic management vs. therapeutic interventions
  
  

This assessment clarified the market gaps, unmet needs, and competitive opportunities across each country.

3. Focus on Moderate-to-Severe Myopia Population

In response to the client’s strategic objectives, our research further zoomed into the moderate-to-severe myopia cluster, evaluating:

• Disease progression risks
• Treatment adoption patterns
• Cost burden and care-seeking behavior
• Future growth potential of treatment-based interventions
  
  

This delivered targeted insights essential for maximized impact at market entry.

4. Strategic Positioning & Differentiation Mapping

Given that symptomatic management dominates most APAC myopia markets, DelveInsight recommended a differentiated product positioning strategy to highlight the therapeutic value of the client’s offering. This allowed the client to position their product as a clinical, outcome-driven alternative to conventional management options.

Outcome

DelveInsight’s comprehensive assessment delivered the following:

• Deep epidemiological insights into pediatric myopia across APAC, detailing prevalence, incidence, severity distribution, and future forecast trends.
• A thorough evaluation of the APAC myopia treatment landscape, revealing competitive dynamics, emerging therapeutic opportunities, and regional market variations.
• Precision-driven recommendations focused on the moderate-to-severe myopia population, enabling the client to align their strategy with the highest-potential segment.
• A clear, differentiated product positioning strategy, offering a competitive edge in markets dominated by symptomatic management.
  
  

Forward-looking market forecasts up to 2032, empowering the client to navigate investment planning, launch optimization, and long-term growth opportunities.